Jeffrey H. Cooper, SVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 25,250 shares at $38.09 ($962K) on 2012-05-14, disclosed to the SEC on 2012-05-16.
Scheduled sale ($962k) by SVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BMRN | SELL | 2011-11-03 | $83K | — | Filing → |
| BMRN | SELL | 2011-10-11 | $625K | — | Filing → |
| BMRN | SELL | 2011-09-29 | $588K | — | Filing → |